Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Terminal ileum

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    35 result(s) found for: Terminal ileum. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2022-001710-19 Sponsor Protocol Number: LUMINALSONAZOID001 Start Date*: 2022-11-01
    Sponsor Name:Medical department, Haukeland University Hospital
    Full Title: Sonographic diagnostics with oral contrast for Crohns. A novel method for detecting Crohns disease using sonographic intraluminal contrast.
    Medical condition: Crohns disease in the terminal ileum
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-010163-16 Sponsor Protocol Number: 08/0285 Start Date*: 2009-06-05
    Sponsor Name:University College London
    Full Title: Bile salt manipulation as a novel treatment for Crohn’s disease: a single centre open label pilot study of atorvastatin and colesevalam in patients with active ileal Crohn’s disease
    Medical condition: Active Crohn's disease affecting the ileum
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011406 Crohn's ileitis LLT
    9.1 10058815 Crohn's disease acute episode LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-003179-23 Sponsor Protocol Number: GS-US-419-4015 Start Date*: 2017-04-13
    Sponsor Name:Gilead Sciences, Inc.
    Full Title: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn’s Disease (SBCD)
    Medical condition: Small Bowel Crohn’s Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) CZ (Completed) ES (Completed) PL (Completed) HU (Completed) FR (Completed) AT (Completed) BE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-001924-40 Sponsor Protocol Number: GED-0301-CD-003 Start Date*: 2017-02-21
    Sponsor Name:Celgene Corporation
    Full Title: A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of mongersen (GED-0301) for the treatment of adult and adolescent subjects with act...
    Medical condition: Active Crohn's disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000016693 10021315 Ileitis terminal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended) GB (Prematurely Ended) CZ (Prematurely Ended) LV (Prematurely Ended) SK (Prematurely Ended) BE (Completed) DE (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended) HU (Prematurely Ended) GR (Prematurely Ended) FI (Prematurely Ended) PT (Prematurely Ended) ES (Prematurely Ended) FR (Prematurely Ended) PL (Prematurely Ended) HR (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-002640-27 Sponsor Protocol Number: GED-301-01-11 Start Date*: 2011-07-14
    Sponsor Name:GIULIANI
    Full Title: A phase II multicenter, randomized, double-blind, controlled vs placebo, dose-finding study on the efficacy and safety of GED-0301, in patients with active Crohn‟s disease (Ileo-Colitis)
    Medical condition: ACTIVE CROHN'S DISEASE
    Disease: Version SOC Term Classification Code Term Level
    14.1 10017947 - Gastrointestinal disorders 10021315 Ileitis terminal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2022-002751-19 Sponsor Protocol Number: 82160 Start Date*: 2023-04-11
    Sponsor Name:Amsterdam UMC
    Full Title: FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients
    Medical condition: Inflammatory Bowel Diseases
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-001925-18 Sponsor Protocol Number: GED-0301-CD-002 Start Date*: 2016-02-24
    Sponsor Name:Celgene Corporation
    Full Title: A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of mongersen (GED-0301) for the treatment of subjects with active Crohn’s disease.
    Medical condition: Active Crohn's disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000016693 10021315 Ileitis terminal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) SE (Completed) SK (Completed) LV (Prematurely Ended) EE (Prematurely Ended) DE (Prematurely Ended) PT (Prematurely Ended) HU (Completed) CZ (Prematurely Ended) AT (Prematurely Ended) ES (Prematurely Ended) DK (Prematurely Ended) BE (Completed) NO (Completed) BG (Prematurely Ended) GR (Completed) HR (Prematurely Ended) FI (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-005226-29 Sponsor Protocol Number: IBD-0337 Start Date*: Information not available in EudraCT
    Sponsor Name:Wolfson Medical Center
    Full Title: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease
    Medical condition: Crohn's disease
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing) BE (Completed) PL (Completed) PT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-000481-58 Sponsor Protocol Number: MLN0002SC-3031 Start Date*: 2016-01-22
    Sponsor Name:Takeda Development Centre Europe, Ltd.
    Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Cr...
    Medical condition: Crohn’s Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Completed) CZ (Completed) NL (Completed) BG (Completed) GB (Completed) DE (Completed) BE (Completed) SE (Completed) DK (Completed) LT (Completed) HU (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2021-002369-17 Sponsor Protocol Number: 2021-01 Start Date*: 2021-07-22
    Sponsor Name:GETAID
    Full Title: Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial, the POMEROL trial.
    Medical condition: Crohn's disease patients having an i2 endoscopic postoperative recurrence 6-12 months after ileocolonic anastomosis.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2016-001278-13 Sponsor Protocol Number: PROSIBD Start Date*: 2016-06-08
    Sponsor Name:Taina Sipponen
    Full Title: Immunologic, genetic and microbiomic predictors of the treatment response for TNFalpha-blocking drugs – prospective follow-up cohort of patients with Crohn’s disease or ulcerative colitis
    Medical condition: Ulcerative colitis and Crohn's disease
    Disease: Version SOC Term Classification Code Term Level
    19.0 10017947 - Gastrointestinal disorders 10045365 Ulcerative colitis LLT
    19.0 10017947 - Gastrointestinal disorders 10013099 Disease Crohns LLT
    19.0 10017947 - Gastrointestinal disorders 10058815 Crohn's disease acute episode LLT
    19.0 10017947 - Gastrointestinal disorders 10057035 Crohn's ileocolitis LLT
    19.0 10017947 - Gastrointestinal disorders 10011405 Crohn's enteritis LLT
    19.0 10017947 - Gastrointestinal disorders 10011406 Crohn's ileitis LLT
    19.0 10017947 - Gastrointestinal disorders 10076318 Crohn's disease relapse LLT
    19.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    19.0 10017947 - Gastrointestinal disorders 10011402 Crohn's disease (colon) LLT
    19.0 10017947 - Gastrointestinal disorders 10075466 Fistulising Crohn's disease LLT
    19.0 10017947 - Gastrointestinal disorders 10066678 Acute ulcerative colitis LLT
    19.0 10017947 - Gastrointestinal disorders 10075465 Fistulizing Crohn's disease LLT
    19.0 10017947 - Gastrointestinal disorders 10011400 Crohn's colitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002093-32 Sponsor Protocol Number: LUM-002 Start Date*: 2019-10-24
    Sponsor Name:Lument AB
    Full Title: Randomised, open, non-inferiority within patient-controlled trial evaluating the diagnostic usefulness of Lumentin® 44 when used as contrast agent in CT-enterography as compared to MRI- enterograph...
    Medical condition: None. Lumentin 44 is a contrast agent. The diagnostic usefulness of CT with Lumentin 44 as contrast agent as compared to MRE will be investigated in this trial. Patients with confirmed small bowel...
    Disease: Version SOC Term Classification Code Term Level
    22.1 100000004848 10011603 CT scan LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2008-006957-42 Sponsor Protocol Number: BUG-2/CDA Start Date*: 2009-10-30
    Sponsor Name:Dr. Falk Pharma GmbH
    Full Title: Double-blind, double-dummy, randomised, comparative, multi-centre phase III study on the efficacy and tolerability of an 8-week oral treatment with 9 mg budesonide once daily vs. 3 mg budesonide th...
    Medical condition: Induction of remission in active Crohn´s disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10017947 - Gastrointestinal disorders 10058815 Crohn's disease acute episode LLT
    14.1 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) HU (Completed) LT (Completed) BG (Completed) CZ (Completed) LV (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2020-005770-99 Sponsor Protocol Number: 1368-0059 Start Date*: 2021-09-24
    Sponsor Name:SCS Boehringer Ingelheim Comm. V
    Full Title: Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab (BI 655130) efficacy in patients with fibrostenotic Crohn’s Disease
    Medical condition: Fibrostenotic Crohn’s Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) IE (Prematurely Ended) NL (Prematurely Ended) DK (Prematurely Ended) SE (Prematurely Ended) NO (Prematurely Ended) PT (Prematurely Ended) IT (Prematurely Ended) FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-001213-34 Sponsor Protocol Number: BUC-52/CDA Start Date*: 2004-11-02
    Sponsor Name:Dr. Falk Pharma GmbH
    Full Title: Double-blind, double-dummy, randomized, multicentre study to compare the efficacy and safety of oral budesonide (9 mg) and oral mesalazine (4.5 g) in moderately active Crohn’s disease patients
    Medical condition: moderately active Crohn’s disease (200 < CDAI < 400)
    Disease: Version SOC Term Classification Code Term Level
    7.0 10011401 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) SK (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-003509-13 Sponsor Protocol Number: MLN0002-3028 Start Date*: 2015-05-15
    Sponsor Name:Takeda Development Centre Europe Ltd
    Full Title: An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
    Medical condition: Crohn's Disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) CZ (Completed) PL (Completed) BE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2017-002258-36 Sponsor Protocol Number: RETIPC/01/17 Start Date*: 2017-11-21
    Sponsor Name:ALFASIGMA S.P.A.
    Full Title: A Phase II, multicentre, double-blind, randomised, placebo-controlled study of Rifaximin delayed release 400 mg tablet: clinical efficacy and safety in the prevention of post-operative endoscopic C...
    Medical condition: Post-operative endoscopic Crohn’s disease recurrence
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004856 10013099 Disease Crohns LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) BE (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) PL (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-000259-33 Sponsor Protocol Number: 06-AnIt-06 Start Date*: 2007-08-16
    Sponsor Name:Department of Anesthesiology and Intensive Care, University Hospital Münster
    Full Title: Perioperative protective effects of lidocaine - clinical study on the route and timing of administration
    Medical condition: patients, scheduled for major elective colorectal surgery
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10040668 Sigmoid hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10009879 Colectomy total PT
    14.0 10042613 - Surgical and medical procedures 10059848 Proctocolectomy PT
    14.0 10042613 - Surgical and medical procedures 10019460 Hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10039153 Right hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10024107 Left hemicolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10063950 Ileocolectomy PT
    14.0 10042613 - Surgical and medical procedures 10042609 Surgery PT
    14.0 10042613 - Surgical and medical procedures 10061778 Colectomy PT
    14.0 10042613 - Surgical and medical procedures 10044083 Total colectomy LLT
    14.0 10042613 - Surgical and medical procedures 10009878 Colectomy partial LLT
    14.0 10042613 - Surgical and medical procedures 10009880 Colectomy transverse LLT
    14.0 10042613 - Surgical and medical procedures 10033684 Panproctocolectomy LLT
    14.0 10042613 - Surgical and medical procedures 10044447 Transverse colectomy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-017595-25 Sponsor Protocol Number: 04-AnIt-09/UKM09_0031 Start Date*: 2011-02-22
    Sponsor Name:University Hospital Muenster
    Full Title: Balanced 6 % HES 130/0.4 vs. balanced crystalloid-based infusion in patients undergoing colorectal surgery
    Medical condition: Patients undergoing colorectal surgery
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10040668 Sigmoid hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10009879 Colectomy total PT
    14.1 10042613 - Surgical and medical procedures 10059848 Proctocolectomy PT
    14.1 10042613 - Surgical and medical procedures 10009877 Colectomy NOS LLT
    14.1 10042613 - Surgical and medical procedures 10019460 Hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10039153 Right hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10024107 Left hemicolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10063950 Ileocolectomy PT
    14.1 10042613 - Surgical and medical procedures 10061778 Colectomy PT
    14.1 10042613 - Surgical and medical procedures 10044083 Total colectomy LLT
    14.1 10042613 - Surgical and medical procedures 10009878 Colectomy partial LLT
    14.1 10042613 - Surgical and medical procedures 10063065 Anterior rectum resection LLT
    14.1 10042613 - Surgical and medical procedures 10009880 Colectomy transverse LLT
    14.1 10042613 - Surgical and medical procedures 10033684 Panproctocolectomy LLT
    14.1 10042613 - Surgical and medical procedures 10044447 Transverse colectomy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-023034-23 Sponsor Protocol Number: B0151003 Start Date*: 2011-06-03
    Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017
    Full Title: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04236921 IN SUBJECTS WITH CROHN’S DISEASE WHO ARE ANTI-TNF INADEQUATE RESPONDERS (ANDANTE)
    Medical condition: Crohn's Disease (active moderate to severe)
    Disease: Version SOC Term Classification Code Term Level
    16.1 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Completed) HU (Completed) GB (Completed) GR (Completed) DK (Completed) DE (Completed) BE (Completed) IT (Completed) CZ (Completed) AT (Completed) SE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 11 20:21:58 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA